Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.5	122.4	13.8	19.5	59.5	16.2	36.8	13.1	224.5	19.3	25.0	5.6	12.4	0.0	6.1	21.9	85.2	5.7	15.0	13.1	15.4	4.8	13.7	6.9	18.4	16.6	85.3	0.0	0.0	15.1	9.8	27.6	7.3	18.9	27.2	13.6	0.0	4.6	21.3	0.2	20.3	9.3	22.9	0.9	0.1	21.2	8.8	10.2	106.2	66.2	10.3	22.9	91.9	0.1	9.6	9.4	0.0	10.3	21.4	19.1	8.9	1.7	14.2	12.6	13.9	34.2	101.0	0.0	11.4	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9	11.9	23.7	50.6	46.4	18.3	34.0	127.0	30.6	24.1	23.9	615.9	7.9	969.9	139.3	102.5	3.0	53.2	0.7	0.0	35.6	1080.2	76.5	15.6	52.0	1.3	331.4	68.3	29.7	89.6	135.4	11.5	73.4	69.6	28.7	93.8	13.6	46.3	62.2	5.8	72.9	43.7	20.2	58.2	30.9	20.7	70.9	10.2	1691.2	45.4	5.0	37.4
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Group enriched"	"Detected in some"	13284	"Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Approved	Cytosol		NA	NA		1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.8	104.7	31.5	101.2	48.3	55.1	100.7	84.1	87.6	85.8	107.3	74.0	107.1	94.7	137.9	84.8	47.1	106.1	63.2	183.3	63.0	41.6	83.1	77.5	84.0	163.3	75.5	112.6	83.2	75.5	64.7	96.3	64.7	141.5	63.1	44.7	66.6	62.5	90.9	198.0	68.4	93.0	78.4	54.0	88.3	102.2	50.6	211.6	106.8	79.1	63.1	44.4	52.4	221.3	78.4	41.1	94.1	76.4	75.0	126.7	50.6	69.1	90.9	123.6	84.3	86.6	235.7	109.4	100.0	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	1628.0	0.0	0.0	0.0	0.0	0.0	1088.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1710.3	0.0	0.0	0.0	0.0	1077.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1138.4	0.0	0.0	0.0
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 1558.3"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA004177	Uncertain		Approved	Cytosol		NA	NA		1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.8	8.9	1.9	6.2	1.5	5.2	1.5	4.1	7.0	5.5	21.8	3.6	5.1	24.7	6.0	6.8	1.8	6.4	14.1	11.1	3.8	4.4	8.0	6.0	8.3	6.0	11.6	10.6	2.3	5.1	0.5	10.8	12.4	4.5	7.8	4.0	1.2	7.2	13.5	3.9	5.0	8.1	2.1	1.7	5.6	7.7	4.0	22.7	15.3	0.7	6.2	5.1	1.0	1.7	1.5	0.6	5.2	4.0	1.7	8.1	2.5	3.7	5.4	7.4	5.5	8.1	7.7	11.5	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5											11.9	25.9	269.9	530.0	703.6	362.0	0.0	315.9	36.1	40.9	40.1	111.9	0.0	94.5	100.6	190.1	242.7	1558.3	46.7	66.6	0.0	38.0	448.8	200.0	94.7	0.0	692.8	311.1	289.1	683.7	930.6	352.7	289.5	877.3	70.3	597.6	553.3	106.3	971.1	380.8	45.3	219.0	478.6	664.3	23.8	81.3	598.3	0.0	258.9	731.1	912.8
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 2651.5;Proximal tubular cells: 6429.5"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.4;NB-4: 13.5;RPMI-8226: 15.6;SH-SY5Y: 13.5;U-2197: 5.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA002198, CAB020827"	Enhanced					NA	NA		930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.4	0.0	3.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.5	0.2	0.4	0.0	0.2	3.1	15.6	0.0	0.0	2.6	13.5	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.4	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	48.6	0.0	0.0	1.0	0.9	448.4	0.0	0.0	143.1	0.0	0.0	525.6	3.8	0.0	0.0	62.6	46.7	221.2	0.0	0.0	0.0	0.0	2651.5	0.2	3.2	0.0	50.3	57.0	0.0	0.0	0.0	0.0	6.4	2.6	0.4	297.3	28.8	0.0	6429.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	5.0	1.5	0.0
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.5	0.5	3.5	14.7	7.4	7.6	0.7	3.9	8.8	3.0	18.5	4.4	0.7	3.5	4.6	3.4	0.8	9.9	2.4	24.1	5.6	3.1	2.3	6.8	2.8	7.5	6.9	2.5	8.0	7.0	3.4	0.3	6.0	0.4	1.3	7.3	4.6	19.1	2.6	3.6	2.9	8.3	5.5	1.6	3.9	2.4	0.4	63.4	0.4	1.0	9.4	16.7	2.2	18.1	0.1	5.8	9.8	5.6	0.9	0.3	1.4	0.5	0.6	43.8	12.5	2.6	28.6	7.1	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4	0.0	12.0	9.3	17.7	6.6	72.2	19.0	5.1	0.0	7.9	7.0	100.1	1.2	3.3	14.2	0.8	8.4	22.7	0.0	8.9	3.9	7.1	4.4	12.7	50.8	4.4	259.0	20.7	16.5	4.7	0.8	8.6	3.7	23.6	58.7	8.7	81.4	11.6	14.0	9.6	1.6	259.1	12.9	17.6	0.4	3.2	9.5	1.3	17.0	3.3	8.0
AMIGO3		ENSG00000176020	"Adhesion molecule with Ig like domain 3"	Q86WK7	3	49716834-49719695	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	23	"Intestinal endocrine cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 12.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.6;HeLa: 5.6;HMC-1: 3.7;SH-SY5Y: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.33e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.92e-3)"	"unprognostic (3.75e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (7.85e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.58e-3)"	2.4	1.3	1.6	1.5	1.7	4.8	1.0	2.8	4.3	1.0	0.9	1.7	5.8	2.0	1.4	4.5	1.8	1.9	1.2	1.6	0.7	2.1	1.0	3.5	1.6	3.6	0.7	0.5	2.0	2.9	0.7	6.6	0.9	1.9	1.9	0.7	1.9	4.1	5.4	11.7	5.3	1.7	0.7	0.9	2.0	1.7	8.7	0.9	8.7	1.7	5.7	3.8	0.8	1.1	0.4	12.6	0.1	0.1	1.1	1.1	0.4	0.2	0.0	0.2	0.0	0.0	0.4	1.2	0.0	0.0	0.1	0.1	4.6	0.5	0.0	0.4	0.0	0.1	2.6	0.0	0.0	0.0	2.5	1.4	0.0	5.6	2.3	0.0	0.8	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.8	0.0	2.6	2.9	1.6	0.0	0.0	0.0	0.1	0.4	0.2	0.0	2.5	1.4	3.7	0.5	0.2	0.0	0.0	0.3	0.7	0.6	0.4	1.3	0.9	0.2	3.1	2.2	0.4	0.0	1.4	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.2	1.1	0.1	0.1	0.4	0.7	0.1	1.1	0.0	12.6	0.4	0.4	1.6	1.7	2.8	4.3	0.7	2.1	0.7	0.5	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 14.7;skin 1: 6.0"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 67.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.6;CACO-2: 13.1;GAMG: 12.4;HAP1: 9.0;K-562: 10.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059933: AB_2684169"	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.4	0.3	0.2	1.2	0.7	0.4	0.7	0.3	0.8	0.8	0.6	0.8	0.2	0.2	0.2	0.6	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.5	0.2	0.2	0.2	0.7	0.1	0.2	14.7	1.4	0.5	0.3	0.5	2.7	0.6	0.2	6.0	1.5	0.2	0.2	0.8	0.3	0.5	0.2	0.2	0.6	3.8	1.2	0.4	0.8	0.1	0.9	0.0	1.3	1.0	0.8	0.3	0.4	1.1	0.0	0.1	0.1	0.0	18.6	0.1	0.1	0.0	0.3	13.1	0.8	0.5	2.7	0.2	12.4	1.8	9.0	0.3	0.0	3.5	4.7	0.3	4.5	1.3	0.0	0.7	3.1	0.0	2.3	0.1	0.0	0.1	0.0	2.7	10.3	0.0	0.0	2.2	0.3	4.7	0.2	2.4	0.0	0.0	4.2	0.4	0.1	0.6	1.5	0.0	0.3	1.6	0.8	2.9	3.3	3.1	0.0	0.0	0.9	0.2	0.0	0.7	0.1	0.0	0.3	2.4	0.0	0.0	0.3	0.0	0.8	1.3	0.0	0.0	0.0	0.4	0.7	0.1	0.2	0.0	0.0	1.0	1.3	0.9	0.0	0.3	0.2	0.7	0.3	0.8	0.2	0.2	0.2	0.2	1.4	0.2	6.0	0.0	0.0	0.3	2.3	0.0	2.0	0.0	2.7	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	67.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.5	14.1	0.0	0.0	0.3
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B, glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076562	"Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		280000	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	18.2	21.3	17.7	12.8	20.9	8.8	26.0	16.1	26.4	15.8	20.8	10.8	13.3	8.7	18.5	14.7	17.5	14.7	17.3	32.9	17.1	17.2	16.2	14.8	14.6	9.1	16.1	19.9	19.0	10.1	22.5	16.9	15.2	15.2	15.6	13.4	14.5	9.9	18.8	19.0	11.4	10.6	25.9	13.6	10.5	14.4	6.8	9.4	7.3	16.5	7.7	9.4	17.6	28.7	4.9	3.6	2.3	2.3	4.4	4.1	1.5	17.9	16.5	12.8	13.5	22.9	24.2	14.2	15.0	17.2	10.6	9.5	8.2	18.0	9.3	19.8	26.4	8.7	13.2	13.0	11.0	15.6	11.8	8.8	29.7	15.6	10.4	11.4	19.6	18.8	14.0	12.1	14.4	11.2	16.2	13.0	13.1	33.0	13.7	16.9	10.0	8.5	7.1	16.8	20.3	3.5	10.5	13.5	12.4	8.9	20.4	17.1	42.1	15.8	18.0	15.3	19.0	15.5	14.4	13.7	16.9	14.9	23.2	20.2	11.2	20.4	8.2	16.8	9.6	16.7	2.3	2.0	0.6	3.8	1.7	4.1	4.2	2.4	3.5	2.2	4.9	3.5	3.2	1.9	4.4	2.3	3.6	2.7	1.5	17.7	20.9	16.1	26.4	17.1	17.2	16.1	19.9	15.2	9.4	6.0	10.7	11.2	8.9	13.9	12.3	31.9	17.8	8.1	7.9	17.4	23.6	8.0	3.3	8.2	4.2	11.2	4.1	0.0	11.0	5.7	12.4	14.8	16.2	12.2	6.9	36.5	13.8	10.4	8.9	2.5	16.4	6.9	15.1	10.0	7.6	7.8	11.0	0.0	20.1	5.4	20.2	12.9	20.3	12.9	15.8	11.3	6.3	6.9	6.6	23.8
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;RH-30: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054971			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		110000	"Nucleoplasm, Nuclear bodies"		"HPA054971: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.5	10.3	5.4	6.5	5.7	1.4	4.6	23.2	5.5	4.9	5.1	4.4	10.1	4.9	9.6	26.1	4.5	7.0	8.6	7.6	3.7	5.0	13.0	45.4	7.8	5.2	6.2	3.3	3.8	8.4	9.9	7.4	2.7	4.4	5.7	4.7	6.8	7.6	8.8	26.0	3.7	7.6	6.3	3.0	3.4	3.8	2.9	3.4	4.5	5.4	4.3	6.9	6.2	3.7	8.2	3.6	3.9	4.8	4.7	8.0	3.0	2.8	0.9	6.1	2.5	3.0	10.8	0.5	2.5	4.3	1.5	2.2	0.0	2.2	3.4	8.3	6.8	2.7	1.2	1.0	7.6	3.1	26.8	0.7	2.3	2.0	5.4	8.0	1.3	1.5	15.2	6.4	3.1	5.0	6.4	2.9	3.9	1.6	2.1	9.7	3.3	1.8	2.0	3.8	8.3	3.3	4.0	18.6	1.3	8.1	5.5	4.7	2.0	3.5	2.1	7.3	5.4	1.7	1.4	2.8	2.5	1.9	2.9	1.7	4.9	1.7	2.9	8.3	5.6	2.3	2.6	2.2	2.2	5.4	2.3	5.0	8.2	2.6	6.6	3.6	6.8	4.8	8.0	3.9	4.7	4.8	1.8	4.5	3.0	5.4	5.7	23.2	5.5	3.7	5.0	6.2	3.3	4.4	3.4	50.6	181.0	3.7	19.6	18.5	9.2	20.3	349.1	56.2	27.3	12.2	11.8	7.6	14.9	35.1	12.9	6.3	8.8	0.0	38.7	3.8	4.5	19.5	9.3	122.9	10.8	7.9	2.4	6.7	8.0	8.9	1.7	8.5	33.7	16.2	9.9	11.7	15.0	7.8	2.8	34.0	15.5	0.0	4.4	3.9	7.9	27.6	3.8	2.9	16.3	26.4
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735575-82751197	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 45.2;Distal tubular cells: 76.3;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		1400000	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	12.0	29.4	25.7	3.1	32.7	8.9	5.0	24.8	48.1	10.0	11.0	44.8	6.4	19.4	7.8	7.0	4.7	11.9	6.6	38.1	24.7	22.8	41.7	34.7	7.4	2.6	28.9	25.3	14.0	14.9	17.9	11.9	5.2	34.2	10.4	8.8	11.4	24.6	11.9	14.8	5.0	12.4	6.6	30.8	4.4	10.7	4.6	25.3	0.0	8.2	3.5	2.7	5.6	4.5	0.2	0.0	0.0	0.0	0.9	0.4	0.2	0.6	8.2	2.3	12.1	3.7	3.1	1.5	1.5	1.1	2.8	1.4	10.7	1.7	0.1	2.1	1.3	2.4	0.3	17.8	1.3	1.0	0.5	1.2	6.3	6.8	33.0	10.1	0.1	5.3	2.6	4.7	1.1	0.0	3.0	5.5	0.5	11.1	0.3	0.5	0.9	0.1	0.1	1.5	3.8	6.8	1.0	0.2	0.0	6.0	2.3	3.7	11.9	2.7	0.6	7.7	2.1	8.0	2.3	1.2	0.2	0.8	2.9	2.2	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	25.7	32.7	24.8	48.1	24.7	22.8	28.9	25.3	34.2	25.3	3.0	1.3	1.4	2.7	1.3	35.7	5.1	2.5	1.4	2.3	29.6	45.2	9.7	76.3	3.2	0.0	2.1	9.2	0.0	1.0	1.9	4.3	3.2	1.1	4.7	6.5	30.2	5.2	4.9	1.2	0.0	4.9	2.0	11.8	1.0	10.1	26.8	2.2	7.0	2.8	38.4	70.5	0.0	5.1	0.3	3.6	1.6	7.0	1.3	8.6	3.0
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716683-82730328	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		14000	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	17.6	18.3	27.9	10.8	26.3	12.3	15.7	19.5	27.3	15.3	17.4	27.4	10.0	11.8	18.4	16.7	16.4	16.6	13.0	12.7	26.1	20.8	18.8	23.1	12.8	12.9	25.7	23.0	21.9	15.3	10.8	11.4	17.1	22.2	17.1	14.4	13.2	17.2	20.0	7.3	16.1	13.6	20.3	30.7	13.7	12.6	8.8	21.6	8.2	15.1	9.8	17.5	12.1	12.9	16.5	23.2	18.5	15.5	18.5	23.0	17.1	10.9	44.3	12.1	16.0	5.9	11.3	10.0	20.6	11.5	19.9	16.3	23.4	7.7	9.0	13.8	16.6	18.4	12.6	11.0	15.6	18.0	6.0	19.5	15.1	24.8	26.9	10.5	10.5	8.5	10.4	18.5	18.9	10.4	12.2	14.3	12.8	14.5	5.7	25.4	20.8	20.5	15.6	5.5	24.1	19.3	15.4	30.8	14.0	14.1	21.1	10.1	21.5	34.0	15.4	16.6	21.9	25.7	15.3	12.6	38.7	13.3	27.3	30.3	11.7	12.8	22.4	18.0	13.4	17.8	17.0	14.2	18.5	20.4	15.5	20.0	15.7	19.9	19.5	11.7	16.5	23.0	16.7	2.1	18.5	8.4	23.2	18.6	17.1	27.9	26.3	19.5	27.3	26.1	20.8	25.7	23.0	22.2	21.6	11.9	12.0	13.7	25.9	13.4	17.8	5.2	20.4	10.7	12.5	10.4	7.9	80.4	19.9	17.2	1.3	11.7	9.5	23.3	9.9	35.3	15.1	14.6	12.7	9.0	28.7	3.2	7.5	11.6	9.4	2.3	26.2	11.8	21.9	28.9	13.3	29.2	14.9	17.3	29.7	15.8	14.3	12.9	17.6	9.7	22.6	13.4	52.3	14.9	16.9	21.3
FPGT	GFPP	ENSG00000254685	"Fucose-1-phosphate guanylyltransferase"	O14772	1	74198212-74234086	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072331			Uncertain	Vesicles		NA	NA			Vesicles		"HPA072331: "	"unprognostic (1.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.18e-3)"	"unprognostic (4.32e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.86e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.91e-1)"	14.6	11.6	10.9	9.1	12.6	3.4	13.0	19.0	15.8	15.9	11.7	13.0	7.5	11.5	17.7	11.1	15.7	15.4	13.3	12.8	10.9	7.1	15.9	13.7	10.8	8.0	15.5	10.6	14.1	10.2	14.2	27.7	10.6	14.4	11.1	11.3	10.6	11.7	9.1	15.7	12.0	12.0	11.8	16.3	11.0	12.3	8.7	13.9	6.6	20.0	6.8	9.2	17.9	12.9	4.3	9.2	15.2	14.9	3.8	5.4	7.4	9.3	7.7	5.8	8.5	13.5	12.7	8.7	12.2	8.2	8.5	10.0	4.3	7.0	5.7	15.1	7.2	9.6	7.8	10.4	11.2	13.5	11.5	4.4	12.9	9.4	7.3	11.3	9.8	10.0	10.4	14.5	8.4	4.0	5.8	8.7	8.0	13.3	6.9	13.2	2.5	5.4	2.0	6.3	12.0	7.0	5.8	13.7	8.0	7.4	6.8	6.1	6.1	9.0	13.3	14.0	1.9	16.0	11.2	7.8	3.7	7.1	20.2	9.2	7.5	5.4	7.6	15.0	9.7	12.5	12.0	14.9	15.2	4.3	14.5	5.0	3.6	4.4	3.9	9.2	4.3	4.9	4.4	4.4	3.8	12.5	0.9	5.4	7.4	10.9	12.6	19.0	15.8	10.9	7.1	15.5	10.6	14.4	13.9	6.0	2.7	0.5	3.7	6.1	7.0	8.7	10.2	9.4	2.3	10.4	2.0	11.0	16.6	5.0	6.1	5.2	9.3	0.0	6.3	9.1	5.8	2.7	4.7	7.9	13.3	3.2	5.8	6.7	9.8	5.7	9.5	10.6	5.0	3.6	7.6	8.4	5.6	7.0	5.3	12.4	4.5	25.8	5.2	8.1	10.6	5.6	5.1	1.8	7.2	1.7
FPGT-TNNI3K		ENSG00000259030	"FPGT-TNNI3K readthrough"		1	74198235-74543982	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"heart muscle: 28.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 7.9;Cone photoreceptor cells: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 5.0;CAPAN-2: 4.6;SiHa: 6.5"									HPA072331			Approved	Vesicles		NA	NA			Vesicles		"HPA072331: "	"unprognostic (6.29e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.37e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.87e-3)"	8.5	5.5	5.4	3.1	6.3	2.7	6.1	16.1	8.2	6.4	6.3	6.6	3.4	2.5	9.3	4.2	6.0	5.7	4.2	28.0	5.4	4.9	6.3	3.7	6.1	3.5	8.0	5.2	5.6	3.1	4.7	15.0	3.8	7.4	5.5	3.7	5.2	5.4	6.0	11.2	8.0	5.1	6.3	8.5	5.9	4.9	4.1	7.1	2.9	5.1	3.0	3.5	5.5	4.9	2.4	2.4	4.9	4.7	0.8	4.9	3.5	0.0	1.1	0.7	1.5	0.8	5.0	0.1	2.1	1.0	0.2	0.4	1.1	4.6	0.1	3.3	0.2	0.0	0.0	0.3	3.1	0.4	0.1	0.2	1.7	0.1	0.1	0.8	0.4	0.3	2.1	2.1	0.2	0.2	0.6	0.2	0.2	0.0	1.7	1.0	0.0	0.1	0.2	0.1	1.7	0.9	2.3	3.9	0.0	0.4	0.0	1.1	3.4	6.5	0.3	0.3	0.0	0.0	2.3	0.1	0.7	0.2	0.2	0.8	0.2	0.1	1.7	1.0	1.0	1.1	3.6	4.1	3.5	1.1	4.7	3.5	2.1	3.9	2.2	2.4	2.4	4.9	2.5	4.9	0.8	1.2	2.1	3.8	3.5	5.4	6.3	16.1	8.2	5.4	4.9	8.0	5.2	7.4	7.1	3.0	0.6	0.0	0.4	0.1	4.9	7.9	2.5	1.4	1.2	0.0	9.8	0.1	0.0	0.1	0.9	0.5	0.0	0.0	0.9	0.1	0.5	0.3	2.3	0.4	0.2	4.8	2.9	2.5	1.9	0.2	2.6	0.1	1.7	0.0	0.0	1.2	0.9	1.4	0.7	0.5	2.7	0.0	0.5	1.8	1.4	0.1	0.0	0.0	0.2	0.2
FUK	FLJ39408	ENSG00000157353	Fucokinase	Q8N0W3	16	70454421-70480274	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041971	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA041971: AB_10795648"	"unprognostic (4.55e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.82e-3)"	"unprognostic (4.85e-2)"	"prognostic favorable (8.91e-4)"	"unprognostic (2.49e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.89e-2)"	"prognostic favorable (8.38e-4)"	6.7	11.3	11.5	9.8	13.2	8.5	7.3	13.9	13.5	7.5	12.1	15.5	15.1	18.5	8.3	11.5	8.2	10.8	9.4	7.2	9.4	7.4	13.1	11.9	8.1	9.1	12.5	12.4	10.5	12.2	17.1	16.4	11.0	9.8	9.1	7.7	12.9	10.8	9.4	9.0	13.0	13.1	6.3	9.3	9.7	12.2	6.1	12.5	7.2	12.0	4.2	11.1	7.6	6.8	4.3	3.2	3.9	4.4	2.9	6.7	2.5	3.1	4.4	2.6	5.7	1.5	1.8	9.9	1.8	2.9	2.4	3.1	3.9	10.3	2.2	8.8	1.7	0.7	4.5	1.8	4.5	1.5	4.2	6.3	2.9	8.0	4.5	3.8	3.7	2.2	3.0	5.3	1.8	4.5	3.6	4.5	4.3	5.4	2.7	1.8	9.8	4.4	8.5	1.6	5.1	2.5	6.5	0.6	9.7	6.1	5.5	4.2	5.1	10.2	3.5	5.2	2.1	15.0	7.2	4.7	1.9	2.5	4.1	2.1	9.6	4.5	4.5	3.4	3.5	4.2	0.6	4.4	1.8	4.8	2.5	4.1	1.9	4.8	4.8	2.7	4.3	6.7	3.1	3.9	2.9	2.8	3.2	3.2	2.5	11.5	13.2	13.9	13.5	9.4	7.4	12.5	12.4	9.8	12.5	3.0	8.1	1.5	1.7	1.0	5.0	4.5	2.5	0.0	3.4	15.7	3.9	4.7	1.7	4.5	0.8	3.6	15.4	0.0	6.3	2.2	2.5	2.6	0.0	5.8	4.2	9.5	4.1	7.4	3.8	1.1	2.8	2.1	1.7	3.6	10.7	4.5	4.5	11.5	6.0	5.5	7.3	0.0	1.7	4.2	2.0	2.4	4.3	2.9	13.6	1.3
GMDS	"GMD, SDR3E1"	ENSG00000112699	"GDP-mannose 4,6-dehydratase"	O60547	6	1623806-2245692	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 143.7;Mucus-secreting cells: 229.6;Undifferentiated cells: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031528	Enhanced					NA	NA		41000			"HPA031528: AB_10601016"	"unprognostic (5.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (4.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.12e-1)"	5.1	4.0	6.6	29.6	8.7	3.2	7.6	6.0	6.8	12.9	34.9	2.7	10.4	42.1	4.1	6.4	29.2	4.9	38.5	4.9	5.6	4.6	9.3	15.1	7.8	11.8	4.1	3.7	4.3	27.1	19.3	8.9	3.0	4.0	8.6	34.2	6.3	40.4	7.6	3.3	4.9	43.7	4.4	3.1	6.0	38.4	9.0	3.4	9.3	5.6	9.0	19.6	6.1	6.7	10.5	13.9	6.8	12.3	12.0	12.4	7.3	13.0	3.0	2.2	15.5	3.6	9.8	5.3	3.6	7.6	6.8	6.4	6.7	7.6	6.2	11.2	3.9	6.7	5.1	6.7	12.8	7.9	8.5	8.1	6.0	3.4	31.4	4.0	9.6	6.7	10.8	4.4	5.3	11.2	6.6	7.9	21.4	3.9	2.9	4.3	7.4	13.2	11.4	3.3	70.9	10.4	6.9	5.0	32.0	16.4	17.2	12.4	2.9	3.3	5.2	8.0	10.5	4.8	6.1	3.4	5.2	3.9	5.2	6.4	6.6	9.3	6.6	3.4	6.7	6.9	6.8	12.3	1.4	7.9	7.6	10.6	10.5	9.5	7.8	13.9	5.5	8.3	11.1	3.8	12.0	6.1	5.8	12.4	7.3	6.6	8.7	6.0	6.8	5.6	4.6	4.1	3.7	4.0	3.4	0.0	5.0	14.9	13.0	3.8	4.4	2.4	15.3	13.4	5.7	36.6	0.0	15.2	101.2	29.5	3.9	19.6	143.7	0.0	61.4	22.6	9.3	41.6	4.6	9.9	12.1	7.9	107.1	16.0	7.3	3.6	11.2	7.1	21.9	16.2	229.6	3.1	49.3	77.7	15.6	27.3	0.6	12.9	10.7	4.2	35.3	5.4	14.0	18.1	123.8	40.1
GMPPA		ENSG00000144591	"GDP-mannose pyrophosphorylase A"	Q96IJ6	2	219498867-219506989	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035512, HPA035513"	Approved		Approved	Nucleoplasm		NA	NA		17000	Nucleoplasm		"HPA035512: AB_2674660, HPA035513: AB_10671934"	"unprognostic (3.43e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.40e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.90e-10)"	"prognostic favorable (5.24e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-1)"	12.0	15.8	10.3	13.6	14.7	9.9	12.9	10.2	14.6	21.1	17.7	16.5	23.2	17.1	16.7	44.3	14.8	14.6	12.0	16.2	10.4	7.0	22.5	54.1	12.8	11.0	15.8	11.5	12.7	39.8	17.6	28.8	21.4	12.2	21.2	20.0	12.6	37.4	20.3	12.6	10.2	23.6	16.0	13.2	21.1	17.6	9.6	14.3	8.9	24.8	8.1	18.4	13.7	13.5	16.6	21.8	29.2	27.0	17.2	18.4	16.0	14.2	11.7	7.3	12.8	28.1	25.0	19.4	24.9	33.4	29.3	36.5	21.5	13.6	7.7	17.7	35.9	18.9	13.5	13.4	21.5	25.5	15.0	11.6	15.1	12.0	38.1	25.4	7.8	17.8	19.1	17.5	27.5	31.3	15.3	17.9	10.0	26.7	22.6	22.7	17.8	7.7	14.8	7.5	17.5	12.8	6.1	7.8	13.8	16.8	9.7	9.4	8.2	10.4	15.8	17.0	16.0	10.5	12.7	10.3	17.0	11.8	30.6	13.5	15.6	6.2	9.3	34.8	8.8	19.0	29.2	26.5	17.7	15.8	26.7	18.4	16.6	12.6	16.6	21.7	10.4	9.4	8.7	5.9	17.2	27.0	21.8	16.3	16.0	10.3	14.7	10.2	14.6	10.4	7.0	15.8	11.5	12.2	14.3	14.9	15.6	10.0	10.6	4.9	6.1	11.8	10.2	6.7	11.4	15.7	5.9	32.0	29.9	19.9	0.5	6.3	37.6	0.0	26.4	64.3	15.8	14.8	18.5	33.8	30.0	1.6	10.4	13.5	17.8	1.9	17.0	17.9	11.8	13.6	41.5	10.3	19.7	34.5	12.7	28.1	3.5	12.9	7.2	4.6	6.4	7.4	39.5	8.5	23.6	11.6
GMPPB	KIAA1851	ENSG00000173540	"GDP-mannose pyrophosphorylase B"	Q9Y5P6	3	49716844-49723951	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014657	Uncertain					NA	NA		10000			"HPA014657: AB_1849852"	"unprognostic (3.48e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (6.19e-6)"	"unprognostic (1.01e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	7.5	17.1	7.6	17.5	8.1	7.4	9.7	4.3	9.6	14.4	13.2	7.2	28.7	12.1	11.5	23.2	15.3	12.6	13.3	10.9	5.2	4.7	13.1	41.3	12.9	15.9	8.3	6.8	10.1	32.0	8.9	23.0	15.3	6.9	16.6	11.3	7.9	50.8	37.2	7.2	8.2	12.2	7.9	4.3	16.8	18.1	6.9	5.8	16.5	16.8	8.6	17.5	8.8	9.3	13.4	34.5	10.1	11.1	5.5	11.2	8.1	17.8	17.5	12.7	7.7	10.2	7.7	13.0	20.7	12.3	21.0	19.9	11.3	13.3	10.5	9.2	12.9	13.0	10.3	10.6	22.3	7.1	9.4	8.7	7.5	19.4	13.3	23.5	11.3	12.1	5.4	9.6	29.7	23.7	6.8	18.9	12.1	5.6	17.3	12.1	13.5	15.4	5.8	7.0	13.3	21.1	5.3	6.4	18.0	11.6	16.8	8.4	8.9	9.4	23.0	6.8	6.5	13.1	7.5	13.1	15.2	14.7	20.5	22.1	20.0	5.4	7.4	16.0	8.0	17.4	10.1	8.6	3.7	10.8	11.0	11.0	13.4	9.5	11.2	8.2	10.3	7.3	8.8	2.2	5.5	11.1	34.5	6.3	8.1	7.6	8.1	4.3	9.6	5.2	4.7	8.3	6.8	6.9	5.8	8.9	15.0	22.9	17.2	0.7	3.1	3.8	12.7	24.1	5.7	17.4	2.0	26.1	24.9	33.3	4.8	8.3	35.4	0.0	44.5	49.4	8.2	47.6	0.0	24.1	35.8	6.4	16.0	11.6	8.9	7.2	14.4	10.5	1.7	62.3	28.8	5.2	32.1	25.9	7.1	19.3	5.4	0.0	3.8	17.4	10.6	1.5	66.5	17.8	26.8	29.7
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 307.9;Horizontal cells: 287.6;Late spermatids: 870.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.7	10.1	13.6	12.9	15.2	11.4	8.6	17.7	46.6	23.7	25.7	2.9	2.0	1.3	14.0	29.7	17.2	15.6	12.7	39.6	22.7	11.8	9.9	44.2	10.8	0.2	17.3	0.8	33.5	17.2	23.1	33.9	75.8	29.8	24.6	6.6	73.7	9.3	32.4	29.5	5.1	2.2	20.8	9.1	45.1	7.8	8.3	0.1	16.4	21.0	13.9	16.4	20.2	39.4	11.7	20.1	21.5	2.9	25.2	35.5	16.2	19.5	24.7	11.3	7.4	3.1	46.0	23.3	10.2	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6	23.8	29.6	15.8	44.3	42.8	67.3	110.0	7.6	32.1	31.8	26.2	51.1	51.0	11.6	26.4	307.9	34.4	10.3	23.3	26.9	78.8	26.0	25.9	22.0	0.8	45.7	287.6	18.0	25.8	31.3	870.1	14.1	40.6	35.4	24.4	21.8	29.7	36.4	11.5	17.3	0.7	85.2	19.4	42.8	4.3	4.4	45.2	99.4	25.4	12.6	42.9
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74833981-74893359	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 26.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	27.0	2.2	4.4	9.5	5.0	20.4	10.8	0.7	4.5	5.3	23.2	7.3	5.7	1.3	2.6	40.1	13.6	4.8	9.1	8.3	2.8	2.3	2.1	1.4	16.5	5.0	8.5	1.1	14.9	3.5	1.1	1.7	13.2	5.4	4.0	19.2	9.6	10.3	0.5	29.3	9.7	8.9	1.7	10.9	7.4	8.7	24.8	7.4	4.3	7.1	22.3	9.2	29.0	8.3	0.8	6.2	26.2	7.1	0.0	0.8	2.0	16.5	0.1	3.8	14.0	32.9	3.4	14.3	6.4	9.4	7.3	10.5	13.2	3.0	12.0	6.2	3.0	9.4	5.7	17.5	13.6	21.2	3.4	3.7	16.3	3.8	18.2	10.4	23.8	26.9	5.8	14.8	13.8	24.3	8.2	3.4	6.9	14.2	0.0	2.1	11.8	5.7	24.4	13.9	15.7	11.5	9.3	8.1	9.3	4.4	23.4	2.8	13.7	4.1	20.9	8.2	5.8	1.1	3.8	2.8	23.3	4.1	9.6	11.7	8.3	2.3	6.0	54.3	17.5	6.0	6.6	7.1	26.2	0.1	5.7	0.3	0.6	0.4	0.1	6.2	0.8	0.7	0.7	5.9	0.0	3.7	0.1	0.8	2.0	4.4	5.0	0.7	4.5	2.8	2.3	8.5	1.1	5.4	7.4	14.9	37.6	2.9	5.5	45.8	6.2	6.0	7.6	0.0	6.8	5.2	78.5	0.7	0.0	4.4	87.9	3.6	116.3	0.0	3.8	12.3	8.5	17.2	21.9	0.0	15.7	20.6	37.5	1.3	14.6	32.5	13.6	18.9	21.9	1.0	32.2	4.3	18.4	86.0	7.4	0.0	43.3	12.9	2.3	3.1	4.5	49.8	6.9	2.2	19.9	69.9
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Group enriched"	"Detected in some"	13	"Hofbauer cells: 32.3;Kupffer cells: 47.9;Macrophages: 21.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		1700000			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2	0.0	1.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	32.3	0.0	0.0	0.6	47.9	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell type enhanced"	"Detected in many"	25	"Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	41.7	0.0	12.9	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.2	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.2	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.5	0.0	0.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2	3.0	3.7	0.8	0.0	0.0	1.0	0.8	30.6	0.0	0.0	15.7	0.0	0.0	1.7	30.8	0.4	0.0	44.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	172.8	19.9	7.0	0.0	9.5	4.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 359.6;Proximal tubular cells: 948.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 18.6;Hep G2: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		NA	NA		320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	14.0	10.7	1.7	6.4	1.2	0.3	1.4	1.0	0.6	1.3	0.8	5.1	3.1	2.1	3.4	0.0	1.5	6.2	5.5	1.8	0.4	5.0	10.1	18.6	2.8	27.1	0.6	2.5	2.2	0.1	0.8	1.6	0.1	0.7	1.2	3.0	3.3	3.6	0.1	9.1	3.0	2.0	2.3	12.7	4.2	10.7	0.8	11.8	1.6	1.7	6.0	9.4	2.1	3.6	4.0	0.6	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.9	3.6	1.8	6.1	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6	3.0	5.9	9.6	2.3	3.2	3.6	1.9	15.3	0.0	1.2	38.4	2.0	2.6	109.5	3.1	0.8	5.8	12.3	0.0	2.6	3.6	1.9	0.9	4.6	359.6	7.5	6.4	5.8	6.7	13.2	3.6	1.7	5.8	8.5	1.0	5.9	8.5	2.7	1.7	1.4	948.1	5.2	0.0	4.5	0.9	6.8	5.9	7.9	4.6	14.3	1.0
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		170000	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	13.6	33.3	24.2	11.2	26.2	7.4	14.7	19.2	33.7	16.7	22.6	26.1	15.3	32.6	15.7	26.8	17.1	20.7	13.4	28.8	22.7	22.2	22.5	30.2	10.6	16.2	28.1	28.3	23.2	34.2	24.7	15.0	11.4	37.4	20.6	23.1	18.3	18.6	17.9	33.3	11.7	27.4	16.4	21.7	14.7	14.3	23.5	17.7	16.4	17.1	15.0	16.6	15.6	11.7	12.8	10.2	2.4	7.4	17.7	27.1	12.9	10.6	14.7	12.2	13.8	28.0	13.6	10.7	9.2	15.0	15.8	22.1	14.5	14.1	15.1	20.0	13.4	12.6	26.6	24.2	26.7	15.0	11.5	30.3	27.1	14.0	15.6	19.9	12.5	8.0	18.1	6.9	14.8	26.7	24.0	21.4	18.2	9.0	12.4	20.3	9.1	13.3	5.5	6.7	16.1	12.6	13.7	11.5	37.0	18.5	12.1	22.9	10.0	10.7	19.4	11.5	18.7	26.5	8.6	9.6	9.5	8.1	7.0	8.9	30.8	18.2	9.9	19.8	18.1	6.9	0.7	7.2	2.4	13.5	7.4	17.5	12.8	18.3	15.4	10.2	12.5	27.1	19.7	1.1	17.7	6.3	8.5	22.7	12.9	24.2	26.2	19.2	33.7	22.7	22.2	28.1	28.3	37.4	17.7	6.0	15.9	13.7	6.7	1.6	21.7	47.5	10.2	5.3	7.9	14.0	3.9	26.1	13.3	15.5	13.7	8.7	34.2	0.0	7.5	9.1	12.2	5.4	15.0	15.8	20.6	33.4	10.4	6.2	5.3	24.3	10.3	5.6	3.3	11.8	18.1	18.3	14.3	17.3	8.1	25.8	16.8	6.5	6.6	23.8	10.1	2.4	13.6	6.9	11.8	4.7
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.4	4.2	12.6	5.6	3.4	4.5	5.1	3.3	5.3	5.6	10.1	7.0	14.3	6.1	5.7	4.6	6.8	8.4	6.9	9.2	5.8	4.5	9.7	11.4	7.9	5.6	8.2	5.4	4.9	2.1	11.3	9.9	3.1	6.2	6.4	11.4	6.0	5.4	8.9	8.0	7.4	5.7	4.0	7.2	10.2	9.8	6.7	4.2	4.8	8.1	3.7	7.9	10.0	6.2	4.5	6.5	3.8	8.1	8.5	6.9	6.0	8.5	5.1	4.8	26.1	7.9	9.2	4.0	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2	17.9	17.9	11.5	5.7	13.7	15.8	12.1	10.2	9.4	7.9	7.0	13.7	13.0	13.3	8.4	4.6	11.3	5.8	0.0	7.4	11.0	11.7	4.8	4.7	11.6	7.8	9.5	6.4	17.2	11.4	13.3	8.9	6.5	1.7	10.0	11.7	7.2	7.8	7.0	12.0	7.8	17.0	0.0	11.1	10.8	19.7	12.9	10.6	15.7	11.8	5.3
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 15.5"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 13.9;Hep G2: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2.0	1.5	0.1	0.0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.9	0.3	1.0	0.0	0.1	0.2	0.0	0.9	0.2	0.6	0.3	0.1	0.6	0.5	0.1	0.3	0.5	0.4	1.1	0.4	0.1	5.5	0.0	0.1	0.6	0.2	0.6	0.1	0.4	0.0	0.0	1.3	0.1	2.2	0.2	0.7	0.6	0.3	0.4	0.4	0.3	0.5	0.2	0.2	0.0	0.4	0.4	0.3	0.5	1.6	0.2	1.2	0.4	0.0	0.2	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.7	2.1	1.5	0.2	0.0	0.0	0.8	0.0	0.8	0.0	1.3	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.5	0.1	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 70.2;Late spermatids: 128.8;Rod photoreceptor cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 13.9;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 16.7;granulocytes: 13.9"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	3.3	6.1	9.8	5.8	16.6	15.7	5.1	2.1	14.6	7.3	16.0	19.5	5.3	23.2	4.0	9.1	7.7	4.5	9.1	22.8	14.1	7.7	22.0	3.6	10.9	5.3	13.4	15.1	4.3	11.9	6.2	27.5	3.0	25.3	3.9	18.1	22.4	6.3	3.5	34.9	6.4	18.7	4.0	17.4	12.5	10.7	6.1	15.1	6.5	38.4	8.8	5.0	3.4	3.6	1.6	16.7	13.9	1.9	1.1	0.4	0.4	9.7	4.3	2.8	4.9	5.9	2.9	4.7	1.4	1.7	2.4	1.3	10.5	14.1	1.7	2.2	2.2	7.4	13.9	2.1	5.2	1.4	0.3	2.1	13.8	10.8	3.9	4.9	0.0	9.7	4.1	8.0	2.3	13.2	2.9	0.5	5.8	9.4	0.1	1.3	2.9	2.3	0.4	3.9	4.7	6.5	0.0	0.0	0.2	3.3	10.1	4.5	2.7	9.1	15.4	11.4	3.2	10.6	1.1	0.2	0.0	5.3	7.5	1.3	4.5	4.4	0.9	6.1	0.0	2.6	1.0	0.9	13.9	0.2	1.9	0.3	1.3	0.1	0.3	0.8	1.6	0.3	0.4	2.6	1.1	1.3	16.7	0.0	0.4	9.8	16.6	2.1	14.6	14.1	7.7	13.4	15.1	25.3	15.1	6.0	42.0	4.5	3.4	13.5	7.3	70.2	5.1	14.7	5.7	15.7	0.0	0.5	21.6	4.0	47.4	2.7	43.0	0.0	6.7	0.4	2.5	6.5	9.2	4.9	4.9	3.2	5.8	1.3	11.3	128.8	2.6	6.0	20.3	1.8	18.9	8.1	10.5	27.7	2.8	30.6	111.9	0.0	3.2	3.1	3.3	10.2	1.3	1.0	27.6	11.2
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.6;skeletal muscle: 135.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 72.7;RPTEC TERT1: 45.9;T-47d: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	105.6	9.0	16.4	25.7	17.9	77.0	43.4	8.5	29.4	6.6	8.8	29.1	10.6	7.4	9.4	6.3	13.0	14.4	22.4	5.7	16.6	13.2	22.1	11.2	15.1	12.1	19.2	12.9	8.0	8.1	4.0	10.2	7.5	20.7	5.4	3.8	19.3	9.1	20.0	135.7	11.8	6.9	6.5	36.0	12.4	6.7	4.6	16.8	3.3	2.9	4.7	10.3	10.3	10.1	1.5	3.6	20.5	7.1	0.8	4.7	2.9	5.2	72.7	5.8	4.7	21.9	2.7	3.0	7.7	5.5	5.8	9.0	3.4	19.3	9.0	5.1	3.3	4.5	17.0	6.2	12.3	6.7	10.7	4.3	5.3	3.7	1.2	1.8	5.1	8.1	1.9	4.1	9.9	2.4	14.8	11.1	6.3	3.9	3.4	4.6	8.6	3.6	4.8	5.6	7.5	5.1	8.2	2.8	3.5	45.9	2.7	5.5	2.2	5.6	6.2	11.0	10.4	47.8	6.1	14.0	6.1	5.6	0.7	9.3	7.0	2.4	8.1	16.7	6.0	9.2	2.2	5.6	5.5	1.8	7.1	4.7	1.5	3.4	2.3	3.6	1.4	2.5	2.4	20.5	0.8	4.1	2.2	3.2	2.9	16.4	17.9	8.5	16.9	16.6	13.2	19.2	12.9	20.7	16.8	71.5	75.9	13.7	14.3	91.1	7.8	17.3	15.3	13.4	42.1	184.9	49.1	0.2	0.0	42.7	5.1	29.2	7.4	0.0	22.5	4.6	29.8	4.3	41.7	11.6	19.4	6.4	8.2	9.2	79.2	6.1	2.6	37.7	43.9	23.4	5.2	0.4	46.2	5.8	6.7	2.4	1.6	0.0	21.1	0.7	1.6	55.8	0.8	21.3	5.4	9.9
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.0	1.5	3.6	3.3	1.2	1.8	7.1	2.5	4.3	5.2	12.6	2.5	1.8	2.2	2.4	1.9	12.4	1.4	1.5	4.4	4.6	1.5	1.2	5.1	3.3	2.7	1.0	0.9	2.3	1.8	6.6	8.3	0.8	22.9	1.2	2.9	1.7	1.9	4.1	1.1	0.3	7.1	2.2	1.0	3.4	0.4	1.7	2.3	2.0	4.7	1.0	2.2	2.7	1.2	9.9	3.7	2.8	2.2	0.3	5.3	2.1	0.6	15.3	8.8	1.9	1.3	36.5	1.8	31.7	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2	0.0	2.2	0.0	0.3	2.9	5.0	0.6	0.0	1.4	1.2	0.0	2.0	11.1	0.0	2.0	2.6	0.4	1.7	0.0	1.3	36.2	1.5	0.4	1.1	0.0	5.3	6.4	4.1	1.8	11.0	2.0	0.9	4.4	1.7	0.0	11.8	3.6	2.9	0.3	0.7	0.0	4.3	0.0	0.8	0.5	0.5	1.5	4.6	0.0	1.5	0.0
PMM1	Sec53	ENSG00000100417	"Phosphomannomutase 1"	Q92871	22	41576894-41589890	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030712, HPA074950"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA030712: AB_10669600, HPA074950: "	"unprognostic (2.66e-1)"	"prognostic favorable (5.92e-4)"	"unprognostic (3.25e-2)"	"prognostic favorable (6.09e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (6.56e-3)"	"unprognostic (5.76e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.70e-1)"	20.8	25.1	24.3	15.2	28.8	15.3	15.0	15.5	27.9	24.7	29.5	12.6	14.1	25.3	12.1	20.1	36.5	24.8	14.7	17.7	19.6	20.6	32.8	32.2	21.7	10.8	20.3	25.5	34.8	30.5	7.7	8.7	9.7	17.8	13.7	13.9	11.8	13.0	17.3	6.6	13.6	22.0	14.3	15.2	6.0	24.5	27.6	13.2	8.8	8.9	12.7	14.7	15.2	13.2	10.6	13.2	24.5	12.7	6.8	27.1	10.3	5.3	9.8	6.7	14.4	19.4	30.2	7.8	21.1	24.1	19.5	21.5	7.8	5.1	5.0	7.1	25.1	14.0	8.0	8.8	13.6	11.0	10.3	13.5	1.2	12.3	16.4	30.8	7.4	8.1	25.1	13.2	20.1	8.5	21.7	3.1	8.1	5.5	17.8	26.4	14.0	5.6	10.7	2.1	25.2	13.2	4.3	7.2	10.3	8.2	5.7	1.9	3.8	17.2	6.2	25.2	5.5	7.0	8.2	2.4	22.0	12.1	20.5	10.8	11.2	10.8	7.9	24.6	6.2	13.2	9.6	12.7	24.5	16.3	10.2	13.8	10.4	16.8	13.8	13.2	10.6	18.3	12.9	16.6	6.8	12.0	5.0	27.1	10.3	24.3	28.8	15.5	27.9	19.6	20.6	20.3	25.5	17.8	13.2	32.8	81.3	24.1	11.2	13.2	18.0	10.2	61.1	46.8	36.4	33.2	5.9	49.2	91.2	22.6	11.4	5.8	103.9	23.3	9.6	78.2	28.7	9.3	3.5	75.7	29.4	27.0	46.8	10.4	11.3	10.8	25.9	14.0	42.2	25.2	41.2	49.6	15.1	112.2	28.7	109.0	19.6	38.8	39.8	45.9	10.4	12.3	54.6	20.3	47.6	5.5
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Club cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.8	24.3	5.4	14.1	9.6	15.2	12.0	17.0	20.6	17.1	18.5	18.2	13.5	17.4	7.2	29.7	9.0	15.1	11.0	20.8	17.5	12.9	12.9	5.7	14.7	31.0	18.3	15.2	13.8	22.7	14.8	18.2	16.8	7.9	17.4	10.8	7.8	17.0	11.3	28.5	15.6	14.0	22.9	25.4	15.8	19.8	12.0	34.6	19.0	19.3	10.3	19.3	14.0	30.9	10.2	9.0	20.1	13.4	20.1	12.3	13.9	33.2	16.6	21.0	17.6	21.9	10.3	19.2	16.3	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8	14.9	17.9	9.8	6.8	3.4	4.8	2.4	5.1	26.8	46.6	0.0	13.7	7.4	8.3	10.9	0.2	4.5	10.2	23.3	24.6	9.5	5.4	9.5	22.0	11.3	5.1	1.6	7.5	3.7	6.0	0.6	5.8	6.3	1.7	8.2	11.5	2.3	17.8	10.2	2.1	10.0	8.9	0.0	5.2	1.6	3.1	3.6	8.9	5.1	9.2	11.3
POLR3H	"KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525804-41544606	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome		NA	NA			Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.8	14.0	30.0	9.1	28.8	5.5	13.5	21.0	27.4	12.1	7.5	15.8	12.6	6.1	10.5	11.7	17.0	19.0	10.3	14.8	24.0	20.5	10.0	18.9	14.7	10.9	22.2	17.6	22.4	13.7	13.1	11.5	7.9	17.2	11.0	6.8	12.1	12.2	14.2	7.7	14.6	6.2	14.4	14.2	7.2	7.9	14.2	16.5	7.0	15.4	8.2	9.3	8.1	9.1	11.6	11.2	0.6	13.8	3.9	10.2	7.5	16.3	11.0	10.2	14.9	11.2	10.2	6.8	13.7	12.8	23.4	18.9	22.2	5.4	13.9	10.8	23.0	13.2	7.5	18.6	22.4	14.7	12.7	23.0	8.3	17.5	10.6	11.6	34.4	14.2	12.7	14.6	30.8	8.3	8.9	11.4	13.9	17.4	8.9	13.0	15.5	8.8	9.4	7.2	21.7	14.3	13.5	8.0	14.5	10.9	9.6	9.8	5.9	17.9	18.2	8.7	6.6	7.2	9.8	10.2	14.0	15.2	24.3	18.1	6.8	12.6	21.0	24.4	12.3	13.3	0.0	10.0	0.1	7.3	13.8	10.2	11.6	7.1	8.6	11.2	10.1	10.0	8.1	0.6	3.9	12.7	10.8	4.4	7.5	30.0	28.8	21.0	26.9	24.0	20.5	22.2	17.6	17.2	16.5	0.0	23.5	18.2	9.8	15.8	16.9	5.1	12.7	9.4	21.6	15.7	15.7	29.8	39.7	26.3	30.8	8.2	2.9	23.3	25.7	23.4	15.5	13.0	11.5	29.7	27.4	20.6	13.7	9.2	6.9	113.5	15.5	10.0	23.6	22.6	4.1	18.5	23.5	7.0	19.1	28.8	20.6	0.0	10.5	44.7	55.2	22.3	15.0	10.2	8.5	11.3
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.6	11.4	11.8	17.4	10.8	12.3	8.8	11.7	11.3	12.6	10.2	11.7	16.5	8.1	12.6	10.0	8.5	8.6	13.3	7.9	10.9	11.8	13.4	18.9	22.3	17.4	13.0	14.6	13.6	13.1	10.6	12.3	11.2	11.6	16.8	14.1	14.3	9.5	10.1	13.7	21.1	6.3	8.5	15.5	6.5	7.0	17.0	15.4	11.5	7.8	15.7	12.2	10.8	13.4	6.7	11.1	23.4	12.0	9.9	12.1	8.9	10.9	19.5	19.1	6.6	14.1	16.5	14.9	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8	8.9	4.0	4.4	2.4	2.1	8.6	1.0	20.4	1.4	4.5	3.5	3.9	5.6	5.0	4.9	10.6	3.6	13.1	0.0	4.8	3.6	4.9	4.4	6.9	23.8	4.8	6.4	6.4	9.8	9.9	12.6	6.9	3.2	3.3	4.6	5.9	3.5	6.0	7.0	5.3	8.5	8.2	0.0	4.9	8.7	9.1	2.6	7.1	2.9	6.3	3.7
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"	17	"Hepatocytes: 654.8;Proximal tubular cells: 226.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		430000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.6	13.8	3.5	11.3	3.0	5.3	3.7	4.3	3.0	9.9	8.4	11.5	8.6	2.0	9.8	5.3	10.7	23.6	18.1	16.4	7.9	34.0	11.2	15.7	18.1	25.3	2.3	27.3	26.4	6.8	12.5	5.7	9.1	4.8	9.3	24.2	17.6	5.6	9.3	6.3	16.5	14.8	13.5	26.5	14.7	0.0	22.8	7.6	7.2	15.3	24.8	13.0	8.9	14.0	6.6	3.9	20.2	11.2	8.3	7.9	7.0	17.6	10.4	1.0	6.9	2.0	12.8	24.1	20.6	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9	0.0	1.9	16.8	20.6	6.9	9.5	2.8	38.2	28.1	28.4	31.4	0.0	1.0	24.9	52.5	26.1	3.8	9.1	0.0	118.4	3.9	5.8	134.4	8.1	654.8	14.4	3.2	81.4	20.9	21.2	17.1	3.4	8.2	15.1	8.2	29.3	6.8	90.9	13.3	5.6	226.9	3.6	0.0	9.2	6.5	2.5	17.8	0.8	6.4	32.6	87.8
TIGAR	C12orf5	ENSG00000078237	"TP53 induced glycolysis regulatory phosphatase"	Q9NQ88	12	4307763-4354593	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 53.0;monocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 36.9;SuSa: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034010, HPA040354, HPA044111"	Approved		Supported	Cytosol		NA	NA			Cytosol		"CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814"	"unprognostic (1.76e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	14.3	14.3	8.3	12.3	10.8	10.5	7.1	3.7	17.8	6.3	10.4	10.1	6.4	6.7	7.5	7.3	10.3	5.7	8.5	9.8	9.5	7.9	7.7	11.0	10.4	12.3	13.5	7.9	6.0	5.2	9.0	14.4	14.6	12.2	7.5	13.5	8.4	8.2	9.5	13.6	6.2	8.7	12.5	12.3	14.9	8.5	8.4	8.3	8.9	6.0	6.6	12.6	13.9	8.9	3.7	14.0	4.7	15.5	3.2	5.7	3.6	5.3	8.6	7.0	8.1	6.6	6.4	36.9	9.3	7.9	7.1	9.7	10.4	5.5	6.0	1.3	6.4	7.6	6.8	7.4	15.9	8.9	7.7	5.4	0.1	5.7	8.5	14.0	3.3	1.2	11.6	19.2	8.3	15.0	4.4	14.4	4.4	0.6	4.5	14.3	7.9	2.9	1.7	15.0	6.3	2.6	4.2	11.4	2.2	6.9	10.9	0.2	4.2	8.8	4.4	11.5	36.2	1.4	2.9	12.4	9.6	12.4	7.5	5.2	3.8	3.8	10.3	6.7	2.3	7.6	0.5	8.2	0.7	3.6	14.4	3.4	3.7	2.8	3.9	14.0	2.9	1.9	3.2	4.7	3.2	15.5	5.5	5.7	3.6	8.3	10.8	3.7	17.8	9.5	7.9	13.5	7.9	12.2	8.3	0.0	1.7	11.5	7.6	0.0	3.3	9.7	2.5	0.0	0.0	5.2	17.7	23.6	13.3	13.4	23.6	8.7	1.6	0.0	12.0	23.6	8.6	7.1	0.0	5.1	53.0	1.6	7.0	5.5	19.7	22.4	3.4	12.3	0.0	43.3	1.8	11.0	13.1	3.5	4.2	7.3	3.1	6.5	6.6	17.0	23.4	0.0	28.7	4.4	2.0	10.8
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235401-74544428	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 44.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 23.4;Early spermatids: 20.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;HSkMC: 2.6;OE19: 2.8;RPTEC TERT1: 2.6"															NA	NA						"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	0.7	0.6	1.1	0.5	1.5	0.0	1.0	6.0	1.7	0.5	0.5	0.5	0.5	0.2	0.5	1.7	0.5	0.7	0.5	44.6	1.1	1.3	2.2	0.5	0.5	0.5	0.6	0.5	0.7	0.5	0.3	0.6	0.5	0.9	0.5	0.3	0.5	0.5	1.2	0.5	0.9	0.5	0.6	0.5	0.5	0.1	1.8	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.3	1.9	0.0	2.3	0.0	1.0	0.1	0.0	0.6	0.7	0.0	0.5	1.5	0.0	0.0	1.3	0.3	1.0	0.0	3.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.5	2.6	1.5	0.2	0.0	0.0	0.5	0.3	0.0	0.8	1.1	0.0	0.2	0.2	1.1	2.8	0.0	0.2	0.0	0.0	2.6	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.8	1.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.0	0.0	0.2	1.9	0.0	0.1	1.1	1.5	6.0	1.7	1.1	1.3	0.6	0.5	0.9	0.5	0.0	0.0	0.0	0.1	0.8	1.2	23.4	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.1	20.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	5.4	0.9	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	3.3	0.2	0.0	1.7	0.4	1.1	0.3	0.1	0.0	0.0	0.1
TSTA3	"FX, P35B, SDR4E1"	ENSG00000104522	"Tissue specific transplantation antigen P35B"	Q13630	8	143612618-143618048	"Enzymes, Predicted intracellular proteins"		"Isomerase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023361	Approved		Approved	Nucleoplasm,Cytosol		Yes	No		600000	Cytosol	Nucleoplasm	"HPA023361: AB_1858420"	"unprognostic (1.37e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.62e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (6.62e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.27e-2)"	9.4	12.0	7.0	9.5	10.1	16.3	10.2	6.1	13.8	8.6	18.7	8.4	16.6	24.8	8.4	9.9	28.0	7.7	23.7	15.7	8.1	7.8	11.7	40.0	8.9	16.5	6.8	8.1	9.7	60.1	6.4	14.2	21.9	12.2	13.9	14.9	9.5	35.4	14.2	16.8	28.4	20.2	6.9	4.7	11.3	35.5	24.6	5.6	14.7	13.0	17.8	24.8	9.8	10.4	18.7	25.6	17.7	21.0	28.1	26.9	20.5	16.4	12.0	6.0	18.0	5.1	4.9	11.2	13.6	13.4	9.7	7.3	14.6	17.5	7.2	13.4	9.6	4.0	11.8	9.1	18.5	4.4	18.6	13.2	10.6	21.2	16.9	10.4	7.1	12.2	6.1	9.6	6.5	23.3	7.9	15.7	12.9	11.8	10.5	7.3	49.8	9.2	10.8	8.2	47.2	16.4	10.6	4.6	22.1	19.6	16.5	12.4	9.7	9.3	18.4	13.7	4.5	23.4	10.4	13.1	6.4	25.6	7.6	13.1	7.9	5.6	5.3	9.9	16.3	9.6	10.5	15.9	17.7	21.0	21.0	21.2	16.1	22.7	22.6	18.0	18.7	16.9	18.7	16.3	28.1	16.3	25.6	26.9	20.5	7.0	10.1	6.1	13.8	8.1	7.8	6.8	8.1	12.2	5.6	14.9	27.3	38.0	42.2	74.1	12.6	12.5	61.1	18.7	12.5	8.7	5.9	73.8	46.4	110.8	79.5	30.8	86.0	46.7	170.3	125.9	25.3	69.4	25.3	62.7	61.4	12.7	59.5	26.4	25.1	197.6	38.0	25.2	28.7	33.3	168.9	16.3	123.1	69.1	32.2	68.8	9.3	12.9	27.2	56.2	48.1	108.3	73.3	42.9	88.1	73.3
